Regulating the Heme Active Site by Covalent Modifications: Two Case Studies of Myoglobin

Chembiochem. 2024 Feb 1;25(3):e202300678. doi: 10.1002/cbic.202300678. Epub 2023 Dec 12.

Abstract

Using myoglobin (Mb) as a model protein, we herein developed a facial approach to modifying the heme active site. A cavity was first generated in the heme distal site by F46 C mutation, and the thiol group of Cys46 was then used for covalently linked to exogenous ligands, 1H-1,2,4-triazole-3-thiol and 1-(4-hydroxyphenyl)-1H-pyrrole-2,5-dione. The engineered proteins, termed F46C-triazole Mb and F46C-phenol Mb, respectively, were characterized by X-ray crystallography, spectroscopic and stopped-flow kinetic studies. The results showed that both the heme coordination state and the protein function such as H2 O2 activation and peroxidase activity could be efficiently regulated, which suggests that this approach might be generally applied to the design of functional heme proteins.

Keywords: X-ray structure; covalent modification; heme active site; heme proteins; protein engineering.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Catalytic Domain
  • Heme* / chemistry
  • Kinetics
  • Myoglobin* / chemistry
  • Myoglobin* / genetics
  • Myoglobin* / metabolism
  • Protein Conformation
  • Sulfhydryl Compounds

Substances

  • Myoglobin
  • Heme
  • Sulfhydryl Compounds